On Friday, July 16, Nexus Pharmaceuticals held a grand opening ceremony to celebrate the ribbon-cutting of the new Nexus manufacturing facility, located at 10300 128th Avenue in Pleasant Prairie. Village President John Steinbrink Sr. was honored to be part of the celebration and thanked the Nexus team, Village staff, and many in attendance for their help in bringing the development forward. The new facility represents a significant investment in the community.
Looking back to 2020, when Nexus began developing the 16-acre property, anticipation grew as the exterior building shell began to form an exciting design that brought a unique look to the landscape in Prairie Highlands Corporate Park. The building turned out beautifully, with the professional craftsmanship, attention to detail, and quality building materials used throughout the manufacturing facility.
Nexus Pharmaceuticals is a welcomed addition to the Pleasant Prairie business community. The company has invested $100 million into the three-story manufacturing facility, including an abundance of cutting-edge technologies. The 84,000 square foot building will support the production and supply of sterile injectable drugs. In addition, the company expects to create more than 77 new jobs in high-tech manufacturing, analytical testing, quality control, and supply chain management.
"I want to thank Nexus Pharmaceuticals for choosing Prairie Highlands Corporate Park and officially welcome the company to the Village of Pleasant Prairie," said Village President John Steinbrink Sr. "I look forward to seeing Nexus continue to grow, thrive in this new location, and to many more tomorrows."